Fatigue and thermo sensitivity affect physical activity in multiple sclerosis

Journal of Applied Research

Volumn 10, Issue 3, 2010, Pages 99-106

  Fjeldstad, Cecilie ^a   Brittain, Danielle R ^b   Fjeldstad, Anette S ^c   Pardo, Gabriel ^a  

^a NeuroScience Institute   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Axonal damage; Demyelination; Heat sensitivity; Relapsing remitting Ms

Indexed keywords

ADULT; AGED; ARTICLE; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; HEAT SENSITIVITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATIENT PARTICIPATION; PHYSICAL ACTIVITY; RATING SCALE; SELF REPORT; SEX DIFFERENCE;

EID: 78449301005     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kraft AM, Wessman HC. Pathology and etiology in multiple sclerosis: a review. Phys Ther. 1974;54: 716-20.
2. Petajan JH, White AT. Recommendations for physical activity in patients with multiple sclerosis. Sports Med. 1999;27: 179-91.
3. Ginis KA, Hicks AL. Considerations for the development of a physical activity guide for Canadians with physical disabilities. Can J Public Health. 2007;98 Suppl 2: S135-47.
4. Kos D, Kerckhofs E, Nagels G, D'Hooghe M B, Ilsbroukx S. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair. 2008;22: 91-100.
5. Mostert S, Kesselring J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler. 2002;8: 161-8.
6. White LJ, Castellano V, McCoy SC. Cytokine responses to resistance training in people with multiple sclerosis. J Sports Sci. 2006;24: 911-4.
7. Sheean GL, Murray NM, Rothwell JC, Miller DH, Thompson AJ. An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain. 1997;120 (Pt 2): 299-315.
8. Guthrie TC, Nelson DA. Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential. J Neurol Sci. 1995;129: 1-8.
9. Selhorst JB, Saul RF. Uhthoff and his symptom. J Neuroophthalmol. 1995;15: 63-9.
10. van Diemen HA, van Dongen MM, Dammers JW, Polman CH. Increased visual impairment after exercise (Uhthoff's phenomenon) in multiple sclerosis: therapeutic possibilities. Eur Neurol. 1992;32: 231-4.
11. Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil. 1984;65: 135-8.
12. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol. 1988;45: 435-7.
13. White LJ, Dressendorfer RH. Exercise and multiple sclerosis. Sports Med. 2004;34: 1077-100.
14. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50: 121-7.
15. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985;10: 141-6.
16. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46: 1121-3.
17. Saboisky J, Marino FE, Kay D, Cannon J. Exercise heat stress does not reduce central activation to non-exercised human skeletal muscle. Exp Physiol. 2003;88: 783-90.
18. Rice CL, Vollmer TL, Bigland-Ritchie B. Neuromuscular responses of patients with multiple sclerosis. Muscle Nerve. 1992;15: 1123-32.
19. Sharma KR, Kent-Braun J, Mynhier MA, Weiner MW, Miller RG. Evidence of an abnormal intramuscular component of fatigue in multiple sclerosis. Muscle Nerve. 1995;18: 1403-11.
20. Dalgas U, Stenager E, Ingemann-Hansen T. Multiple sclerosis and physical exercise: recommendations for the application of resistance-, enduranceand combined training. Mult Scler. 2008;14: 35-53.
21. Schauf CL, Davis FA. Impulse conduction in multiple sclerosis: a theoretical basis for modification by temperature and pharmacological agents. J Neurol Neurosurg Psychiatry. 1974;37: 152-61.
22. Pandolf KB. Effects of physical training and cardiorespiratory physical fitness on exercise-heat tolerance: recent observations. Med Sci Sports. 1979;11: 60-5.
23. Noronha MJ, Vas CJ, Aziz H. Autonomic dysfunction (sweating responses) in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1968;31: 19-22.
24. Marino FE. Heat reactions in multiple sclerosis: an overlooked paradigm in the study of comparative fatigue. Int J Hyperthermia. 2009;25: 34-40.
25. Cartlidge NE. Autonomic function in multiple sclerosis. Brain. 1972;95: 661-4.
26. Comi G, Leocani L, Rossi P, Colombo B. Physiopathology and treatment of fatigue in multiple sclerosis. J Neurol. 2001;248: 174-9.
27. Fragoso YD, Santana DL, Pinto RC. The positive effects of a physical activity program for multiple sclerosis patients with fatigue. NeuroRehabilitation. 2008;23: 153-7.
28. DeBolt LS, McCubbin, J.A. The Effects of Resistance Training on Fatigue and Depression in Adults With Multiple Sclerosis. Medicine & Science in Sports & Exercise 2003:S232.
29. Andreasen AK, Jakobsen J, Petersen T, Andersen H. Fatigued patients with multiple sclerosis have impaired central muscle activation. Mult Scler. 2009;15: 818-27.
30. White LJ, McCoy SC, Castellano V, Gutierrez G, Stevens JE, Walter GA, et al. Resistance training improves strength and functional capacity in persons with multiple sclerosis. Mult Scler. 2004;10: 668-74.
31. Dodd KJ, Taylor NF, Denisenko S, Prasad D. A qualitative analysis of a progressive resistance exercise programme for people with multiple sclerosis. Disabil Rehabil. 2006;28: 1127-34.
32. Baker DG. Multiple sclerosis and thermoregulatory dysfunction. J Appl Physiol. 2002;92: 1779-80.
33. White AT, Wilson TE, Davis SL, Petajan JH. Effect of precooling on physical performance in multiple sclerosis. Mult Scler. 2000;6: 176-80.
34. Powers S, Howley, ET. Exercise Physiology. Therory and Application to Fitness and Performance. Third ed 1997.
35. Syndulko K WA, Baumhefner RW, Tourtellotte WW. Preliminary evaluation of lowering tympanic temperature for the symptomatic treatment of multiple sclerosis. J Neuro Rehab. 1995;9: 205-15.
36. Heider W, Gottlob I. [A differential diagnostic test for optic neuritis]. Klin Monbl Augenheilkd. 1987;190: 420-3.
37. Harlaar J, Ten Kate JJ, Prevo AJ, Vogelaar TW, Lankhorst GJ. The effect of cooling on muscle co-ordination in spasticity: assessment with the repetitive movement test. Disabil Rehabil. 2001;23: 453-61.
38. Flensner G, Lindencrona C. The cooling-suit: case studies of its influence on fatigue among eight individuals with multiple sclerosis. J Adv Nurs. 2002;37: 541-50.
39. Davis FA, Stefoski D, Rush J. Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol. 1990;27: 186-92.
40. Jones RE, Heron JR, Foster DH, Snelgar RS, Mason RJ. Effects of 4-aminopyridine in patients with multiple sclerosis. J Neurol Sci. 1983;60: 353-62.
41. Stefoski D, Davis FA, Faut M, Schauf CL. 4-Aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol. 1987;21: 71-7.
42. Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, et al. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet. 2009;373: 732-8.
43. Judge SI, Bever CT, Jr. Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006;111: 224-59.